Back

Functional characterisation of AI-prioritised sarcomeric variants in hypertrophic cardiomyopathy using iPSC-derived cardiomyocytes

29 August 2026 (10:45 - 10:57)
Organised by: Logo
Congress Presentation Part of: Translational, genetic, and precision medicine approaches Genetics, Epigenetics, ncRNA ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Iswaree Balakrishnan

National Heart Centre Singapore, Singapore (Singapore)

4 More presentations in this session

Presentation thumbnail
Cardiac in vivo correction of the PLN R14del cardiomyopathy mutation using prime editing
Doctor V. Rajendran (Munich, DE)
Abstract Slides Video
Presentation thumbnail
A novel serum biomarker molecule for heart failure progression： VDAC3 protects against heart failure by aediating SLC25A11 stability and repairing ATP synthesis
Professor C. Yan (CN)
Abstract Slides Video
Presentation thumbnail
A DNA damage checkpoint drives phenotypic transition in cardiomyopathy
Doctor J. Komuro (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes in a large-scale ventricular septal defect cohort: impact of anatomical subtype and intervention timing
Doctor S. Goo (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Translational, genetic, and precision medicine approaches
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Human-based computational and experimental investigation of disease mechanisms in mutation-specific hypertrophic cardiomyopathy
24 April 2021
thumbnail
Congress Presentation
Introns in action: decoding deep intronic MYBPC3 variants in hypertrophic cardiomyopathy with patient-derived iPSCs
1 September 2025
thumbnail
Congress Presentation
Gain-of-function vs. loss-of-function effects of DES variants on cardiodesminopathy phenotypes
1 September 2025
thumbnail
Congress Presentation
Prevalence of MYL2 and MYL3 rare variants among patients with hypertrophic cardiomyopathy in Hungary
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources